Insider buying last 90 days
No open-market insider purchases were filed for CLMT in the last 90 days.
From Form 4 filings, dated to when each was filed.
Sep 28 close
Calumet's week centers on financing and valuation. The company expanded its asset-based loan facility to $600 million and secured a final $34 million draw from a Department of Energy loan guarantee for Montana Renewables, moves that investors reacted positively to. Coverage also referenced Q2 2026 revenue rising to $1.45 billion alongside an adjusted loss of $1.09 per share, and Calumet presented at the TD Cowen Annual Energy Conference. Brokerage commentary this week settled on a consensus "Hold" rating, with one report noting an average 12-month price target of $51.75 versus a trading price of $53.65, while a separate valuation service flagged the shares as significantly overvalued relative to its own fair value estimate.
The stock closed at $52.61, down 1.9% on the day, but remains above both its 50-day ($49.09) and 200-day ($34.42) moving averages, with the shorter average above the longer one. Momentum has been strong, with one-month, three-month and six-month returns of 14.9%, 46.8% and 64.1% respectively. The GekkoIndex reads 58.3, placing it in the Neutral zone, while the price sits 19.3% above Gekko Fair Value of $44.11.
Calumet's next earnings report is set for 6 November 2026, 38 days out and beyond a typical 20-trading-day holding window; the prior report showed an adjusted loss of $0.05 per share against a $0.23 estimate, with an 8.6% reaction. No insider, Congress or unusual options activity appears in the recent windows. Seasonality over the next 20 trading days has averaged 16.8% across 5 years, rising in 4 of them, a pattern worth noting alongside the current gap to fair value.
Written by AI and checked automatically against the figures on this page. Generated Sep 29, 2026 from the data above.
Calumet scores 3 supportive, 1 mixed and 1 headwind across the 5 checklist items with data.
Six things swing traders check before a 20-day hold, read from the latest data.
3 supportive1 mixed1 headwind
Above 50 and 200-day
Close $52.61 is above the 50-day ($49.09) and 200-day ($34.42) averages, and the 50-day is above the 200-day.
See the chart58.3, Neutral
Reading 58.3 is in the Neutral zone.
See the GekkoIndex19.3% above
Price is 19.3% above Gekko Fair Value (more than 5% above).
See fair valueNo data
No insider, Congress or unusual options activity in the window.
See smart moneyReports in 38 days
Next report Nov 6, 2026, 38 days away — outside a typical 20-trading-day hold.
See earnings+16.8% on average
From this point in the calendar, the next 20 trading days averaged +16.8% over 5 years, rising in 4 of them.
See seasonalityA description of current data, not a recommendation. How this page works
Calumet closed at $52.61 on Sep 28, 2026, +179.5% over the past year, inside a 52-week range of $17.42 to $59.87.
Use the left and right arrow keys to read daily values.
Put CLMT on a Gekko watchlist and see its GekkoIndex, Gekko Fair Value and smart money signals update on the chart as they change.
Calumet makes and sells specialty branded products along with renewable fuel, combining formulation work with manufacturing to serve customers who need tailored fuel and product solutions. Among its recognizable offerings are brands such as Royal Purple, Bel-Ray, and TruFuel.
The company organizes its work into distinct segments. One focuses on customer-driven formulation and specialty solutions, another centers on facilities in Montana, including a specialty asphalt plant in Great Falls and a renewables facility, and a third houses its branded performance products. A separate corporate segment covers general and administrative costs that are not tied to the other business lines.
Calumet was founded in 1919 and is headquartered in Indianapolis, Indiana. Its shares are listed on the NASDAQ under the ticker CLMT.
Calumet’s GekkoIndex — Gekko’s 0 to 100 smart money score — reads 58.3, in the Neutral zone, up 14.9 points over five sessions.
Up 14.9 points over five sessions, from the Distribution zone.
Reading for Sep 28, 2026
| Zone | Readings | 5 days | 20 days | ||
|---|---|---|---|---|---|
| Buying | 64 | +1.0% | +11.9% | ||
| Accumulation | 112 | +1.3% | +3.7% | ||
| Neutral (current zone) | 423 | +1.5% | +4.4% | ||
| Distribution | 70 | +0.3% | +5.1% | ||
| Selling | 3 | Too few readings yet | |||
Average CLMT share-price change over the trading days after each daily reading in its GekkoIndex history. Across every stock Gekko tracks, Neutral readings averaged +1.1% over 20 days. Past behaviour doesn’t guarantee future results.
Neutral zone: No clear directional signal. About the five zones →
Calumet trades 19.3% above Gekko Fair Value of $44.11, so the shares are overvalued on Gekko’s estimate.
Gekko’s own estimate of what Calumet shares are worth, recalculated every trading day.
$44.11
Gekko Fair Value, Sep 29, 2026
19.3% Overvalued
No open-market insider purchases were filed for Calumet, and no Congress trades were disclosed, in the last 90 days.
Plus buybacks, unusual options and fund positions, each dated to when it became public.
No open-market insider purchases were filed for CLMT in the last 90 days.
From Form 4 filings, dated to when each was filed.
No trades in CLMT were disclosed by members of Congress in the last 90 days.
From congressional disclosures, which report amounts as ranges.
Calumet has been buying back its own shares.
From company filings.
2of the funds Gekko tracks hold CLMT.
Calumet reports on Nov 6, 2026, before the open (38 days away), and beat the EPS estimate in 5 of its last 8 reports.
Nov 6, 2026
Expected before the open, 38 days away
| Reported | EPS | Revenue | Move |
|---|---|---|---|
| Aug 7, 2026 | −$0.05 est −$0.23 | $1.45B est $1.12B | +8.6% |
| May 8, 2026 | −$0.64 est −$0.57 | $1.03B est $1.00B | −6.6% |
| Feb 27, 2026 | −$0.43 est −$0.67 | $1.04B est $1.06B | −9.3% |
| Nov 7, 2025 | −$0.21 est −$0.30 | $1.08B est $1.04B | −1.8% |
| Aug 8, 2025 | −$1.70 est −$0.44 | $1.03B est $1.15B | −11.0% |
| May 9, 2025 | −$1.03 est −$0.41 | $993.9M est $922.3M | +10.5% |
| Feb 28, 2025 | −$0.17 est −$0.37 | $949.5M est $866.2M | −10.1% |
| Nov 8, 2024 | −$0.52 est −$0.86 | — | +9.8% |
“Move” is the close of the first session after the report compared with the close of the last session before it, so it reads the same whether the company reported before the open or after the close.
Analysts’ average 12-month price target for Calumet is $53.40, +1.5% from the last close, from 5 firms rating the stock in the last 90 days.
Each firm’s latest rating in the last 90 days: 5 firms.
| Date | Firm | Target | vs price |
|---|---|---|---|
| Sep 22 | H.C. Wainwright | $75 | +42.6% |
| Sep 2 | H.C. Wainwright | $75 | +42.6% |
| Sep 2 | H.C. Wainwright | $75 | +42.6% |
| Sep 1 | Bank of America Securities | $60 | +14.0% |
| Aug 25 | UBS | $47 | −10.7% |
Gekko doesn’t publish price predictions. These are analyst targets and historical base rates, which don’t guarantee future results.
Over the next 20 trading days from Sep 29, Calumet averaged +16.8% across the last 5 years, rising in 4 of them.
| Window | Average | Years higher |
|---|---|---|
| Next 5 trading days | +7.9% | 3 of 5 |
| Next 10 trading days | +14.0% | 3 of 5 |
| Next 15 trading days | +15.5% | 4 of 5 |
| Next 20 trading days | +16.8% | 4 of 5 |
| Next 30 trading days | +24.5% | 4 of 5 |
For scale, CLMT’s typical 20-trading-day move in either direction is about 10.2%.
Calumet’s market cap is $4.58B and revenue of $4.59B over the last twelve months.
Coverage of Calumet this week reads neutral: 1 positive, 5 neutral and 1 negative headlines.
Calumet’s 6 largest industry peers by market value, with today’s move, GekkoIndex zone and gap to Gekko Fair Value.
| Stock | GekkoIndex zone | vs Fair Value |
|---|---|---|
| MPCMarathon Petroleum | Neutral | 1.3% above |
| VLOValero Energy | Neutral | 15.3% above |
| PSXPhillips 66 | Neutral | 14.4% above |
| DINOHF Sinclair | Neutral | 22.3% above |
| PBFPBF Energy | Neutral | 3.4% below |
| CVICVR Energy | Neutral | 57.8% above |
A peer links to its own page where one exists.
Calumet’s market cap is $4.58B at the Sep 28, 2026 close of $52.61, with 87.90M shares outstanding.
The consensus analyst 12-month price target for Calumet is $53.40, +1.5% from the last close. Of the 5 firms that rated the stock in the last 90 days, 2 rate it a buy, 3 a hold and 0 a sell. Gekko doesn’t publish price predictions of its own.
On Gekko’s estimate Calumet is overvalued: the Sep 28, 2026 close of $52.61 is 19.3% above Gekko Fair Value of $44.11. Gekko Fair Value is recalculated every trading day, and a gap inside 5% either way counts as about fair value.
Calumet is expected to report on Nov 6, 2026, before the market opens (38 days away). Analysts expect earnings of $1.55 per share on revenue of $1.26B. Calumet beat the earnings estimate in 5 of its last 8 reports, moving 8.5% on average across the report.
Calumet’s 52-week high is $59.87 and its 52-week low is $17.42; it closed at $52.61 on Sep 28, 2026, +179.5% over the past year.
Gekko describes the data; it does not make buy or sell recommendations. On the swing-trade checklist, 3 of the 5 items with data read as supportive (trend, earnings risk and seasonality), 1 as mixed (gekkoindex) and 1 as a headwind (fair value). The checklist is a description of current data, not a recommendation.
During US trading hours the price at the top of the page is a delayed quote, refreshed every 15 minutes; everything else is rebuilt after each US market close. The GekkoIndex, Gekko Fair Value and the checklist are Gekko’s own, and the Gekko Brief is written by AI from this page’s data and checked against it before it is published. How Gekko’s data works →
Every GekkoIndex reading, insider trade, options bet and Congress disclosure plotted on the chart, plus the 5,800-name screener and trade planning tools.
Join 1,380 other traders using Gekko
Start Your FREE 7 Day Trial → Every feature unlocked. No credit card required.Type a ticker or company name. Press Esc to close.